NEXI-001
Treatment Description
NEXI-001 is an experimental CD8+ T cell product being tested in patients with Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS).
Participating Centers
There is one center running trials with this treatment. Enter a location below to view the distance.